Publisher
Springer International Publishing
Reference32 articles.
1. Baumeister, A. A., Hawkins, M. F., & Uzelac, S. M. (2003). The myth of the reserpine-induced depression: Role in the historical development of the monoamine hypothesis. Journal of the History of Neurosciences, 12(2), 207–220.
2. Brunton, L., Lazo, J., & Parker, K. (2005). Goodman & Gilman’s, the pharmacological basis of therapeutics (11th ed.). New York: McGraw-Hill Medical.
3. Carlsson, A. (1999). Birth of neuropsychopharmacology–impact on brain research. Brain Research Bulletin, 50(5–6), 363.
4. Carlsson, A., & Carlsson, M. L. (2006). A dopaminergic deficit hypothesis of schizophrenia: The path to discovery. Dialogues in Clinical Neurosciences, 8(1), 137–142.
5. Carlton, P. L., & Monowitz, P. (1984). Dopamine and schizophrenia: An analysis of the theory. Neuroscience and Biobehavioral Reviews, 8(1), 137–151.